Onconetix, Inc.
ONCO · XNASCIK 1782107fmd_0SS68XDX7M28B116EXY2NY87QAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Jun 30, 2026, 22 periods
Latest annual · FY2025
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (18)
- Net income
- (14)
- Free cash flow
- (11)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (3)
- Net income
- (3)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
Onconetix, Inc. (ONCO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $815,371 | $2.5 million | -67.7% | 10-K 2026-03-13 · proof |
| Gross profit | $632,913 | $1.1 million | -40% | 10-K 2026-03-13 · proof |
| Operating income | -$17.9 million | -$56.5 million | 10-K 2026-03-13 · proof | |
| Net income | -$14 million | -$58.7 million | 10-K 2026-03-13 · proof | |
| Cash from operating activities | -$9.7 million | -$10.5 million | 10-K 2026-03-13 · proof | |
| Total assets | $24.9 million | $28.2 million | -11.5% | 10-K 2026-03-13 · proof |
| Total liabilities | $9.2 million | $18.6 million | -50.7% | 10-K 2026-03-13 · proof |
| Cash and cash equivalents | $5.2 million | $646,500 | +707.5% | 10-K 2026-03-13 · proof |
- What was Onconetix, Inc. (ONCO)'s revenue in fiscal 2025?
- Onconetix, Inc. (ONCO) reported revenue of $815,371 for fiscal 2025 (the year ended Dec 31, 2025), against $2.5 million the year before (-67.7%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was Onconetix, Inc. (ONCO)'s gross profit in fiscal 2025?
- Onconetix, Inc. (ONCO) reported gross profit of $632,913 for fiscal 2025 (the year ended Dec 31, 2025), against $1.1 million the year before (-40%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was Onconetix, Inc. (ONCO)'s operating income in fiscal 2025?
- Onconetix, Inc. (ONCO) reported operating income of -$17.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$56.5 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was Onconetix, Inc. (ONCO)'s net income in fiscal 2025?
- Onconetix, Inc. (ONCO) reported net income of -$14 million for fiscal 2025 (the year ended Dec 31, 2025), against -$58.7 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was Onconetix, Inc. (ONCO)'s cash from operating activities in fiscal 2025?
- Onconetix, Inc. (ONCO) reported cash from operating activities of -$9.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$10.5 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are Onconetix, Inc. (ONCO)'s total assets?
- As of Dec 31, 2025, Onconetix, Inc. (ONCO) reported total assets of $24.9 million, against $28.2 million a year earlier (-11.5%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are Onconetix, Inc. (ONCO)'s total liabilities?
- As of Dec 31, 2025, Onconetix, Inc. (ONCO) reported total liabilities of $9.2 million, against $18.6 million a year earlier (-50.7%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are Onconetix, Inc. (ONCO)'s cash and cash equivalents?
- As of Dec 31, 2025, Onconetix, Inc. (ONCO) reported cash and cash equivalents of $5.2 million, against $646,500 a year earlier (+707.5%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ONCO&period_type=annual&limit=5"Information only, not investment advice.